Androgel
Product Images NDC 17139-562

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Androgel (NDC 17139-562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Therapeutics U.s., Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Andro Shoulders Ben 05092014 (Androgel 1 62 Spl 01)

Andro Shoulders Ben 05092014 (Androgel 1 62 Spl 01)
FDA Label Image

Andro Shoulders Ben 0509201 (Androgel 1 62 Spl 011)

Andro Shoulders Ben 0509201 (Androgel 1 62 Spl 011)
FDA Label Image

Andro Shoulders (Androgel 1 62 Spl 012)

Andro Shoulders (Androgel 1 62 Spl 012)
FDA Label Image

Andro Shoulders Side View (Androgel 1 62 Spl 02)

Andro Shoulders Side View (Androgel 1 62 Spl 02)
FDA Label Image

The Active Pharmacologic Ingredient In Androgel 1.62% Is Testosterone. Testosterone Usp Is A White To Almost White Powder Chemically Described As 17-beta Hydroxyandrost-4-en-3-one. The Structural Form (Androgel 1 62 Spl 03)

The Active Pharmacologic Ingredient In Androgel 1.62% Is Testosterone. Testosterone Usp Is A White To Almost White Powder Chemically Described As 17-beta Hydroxyandrost-4-en-3-one. The Structural Form (Androgel 1 62 Spl 03)
Testosterone is a hormone that plays an important role in the development and maintenance of male reproductive tissues and secondary sexual characteristics. The given text seems incomplete and only mentions the molecular weight of testosterone as 28842 MW. The term "Cult0" is likely a mistranslation or error. Therefore, the description is limited and incomplete.*
FDA Label Image

Figure 2: Mean (±sd) Serum Total Testosterone Concentrations On Day 7 In Patients Following Androgel 1.62% Once-daily Application Of 81 mg Of Testosterone (n=33) For 7 Days (Androgel 1 62 Spl 04)

Figure 2: Mean (±sd) Serum Total Testosterone Concentrations On Day 7 In Patients Following Androgel 1.62% Once-daily Application Of 81 mg Of Testosterone (n=33) For 7 Days (Androgel 1 62 Spl 04)
FDA Label Image

Figure 3 (Androgel 1 62 Spl 05)

Figure 3 (Androgel 1 62 Spl 05)
This appears to be a medical report with information on Mean Total Testosterone levels of participants on Day 112. The report appears to have two groups, with one group receiving different doses of Androge 162%, while the other group was administered a placebo. The normal range for Total Testosterone levels is noted as 300-1000 ng/d, but no specific values for the participants are listed.*
FDA Label Image

Figure 4 (Androgel 1 62 Spl 06)

Figure 4 (Androgel 1 62 Spl 06)
FDA Label Image

Ndc 17139-562-88 Clear (Androgel 1 62 Spl 07)

Ndc 17139-562-88 Clear (Androgel 1 62 Spl 07)
FDA Label Image

Ndc 17139-562-31 Clear (Androgel 1 62 Spl 08)

Ndc 17139-562-31 Clear (Androgel 1 62 Spl 08)
FDA Label Image

30units (Androgel 1 62 Spl 09)

30units (Androgel 1 62 Spl 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.